Clemens Liebrich

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers

Karl Ulrich Petry, Clemens Liebrich, Alexander Luyten et al. · Papillomavirus Research · 2017 · 57 citations · Full text

Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents.

Clemens Liebrich, Oliver Brummer, Reinhard von Wasielewski et al. · PubMed · 2009 · 48 citations

Invasive Cervical Cancer, Young Adolescents, Gynecology +18

Rare ATAD5 missense variants in breast and ovarian cancer patients

Ivana Maleva Kostovska, Jing Wang, Natalia Bogdanova et al. · Cancer Letters · 2016 · 34 citations

Genetic Epidemiology, Gynecology, Pathology +6

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

Siddhartha Kar, Daniel Considine, Jonathan P. Tyrer et al. · Human Genetics and Genomics Advances · 2021 · 17 citations · Full text